Intellia Therapeutics (NTLA) Tops Q2 EPS by 8c, Revenues Beat

Go back to Intellia Therapeutics (NTLA) Tops Q2 EPS by 8c, Revenues Beat
(NASDAQ: NTLA) Delayed: 15.16 -0.59 (3.75%)
Previous Close $15.75    52 Week High $30.40 
Open $15.43    52 Week Low $11.86 
Day High $15.93    P/E N/A 
Day Low $15.06    EPS $0.00 
Volume 3,161,327